Daclatasvir and reduced-dose sofosbuvir: An effective and pangenotypic treatment for hepatitis C in patients with estimated glomerular filtration rate <30 mL/min-Reference-Cited by-同舟云学术

Daclatasvir and reduced-dose sofosbuvir: An effective and pangenotypic treatment for hepatitis C in patients with estimated glomerular filtration rate <30 mL/min

Published:2019-02-27 Issue:3 Volume:24 Page:316-321
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Goel Amit¹,Bhadauria Dharmendra S²,Kaul Anupma²,Verma Prashant³,Mehrotra Mayank⁴,Gupta Amit²,Sharma Raj K²,Rai Praveer¹,Aggarwal Rakesh¹

Affiliation:

1. Department of Gastroenterology; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Lucknow India

2. Department of Nephrology; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Lucknow India

3. Departments of Gastroenterology; Ram Manohar Lohia Institute of Medical Sciences; Lucknow India

4. Departments of Gastroenterology; Regency Hospital; Kanpur India

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.13222/fullpdf

Reference35 articles.

1. Hepatitis C virus and kidney disease;Martin;J. Hepatol.,2008

2. HCV and the kidney;Corouge;Liver Int.,2016

3. Hepatitis C virus infection in chronic kidney disease;Ladino;J. Am. Soc. Nephrol.,2016

4. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO);Kidney Int. Suppl.,2008

5. Interferon-based treatment of hepatitis C virus infection reduces all-cause mortality in patients with end-stage renal disease: An 8-year nationwide cohort study in Taiwan;Hsu;Medicine (Baltimore),2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

2. Rescue use of pegylated interferon in dialysis patient who failed to respond sofosbuvir;Indian Journal of Nephrology;2023

3. Clinical profile and response to treatment in chronic hepatitis C and renal disease: A prospective study from North India;Journal of Integrative Medicine and Public Health;2023

4. Micro-elimination of hepatitis C in patients with chronic kidney disease: an Egyptian single-center study;The Egyptian Journal of Internal Medicine;2022-07-08

5. Efficacy of Low Dose Sofosbuvir and Daclatasvir in Treatment of Chronic Hepatitis C in End Stage Renal Disease;Pakistan Journal of Medical and Health Sciences;2022-01-18